23/04/2024
A team of researchers at The University of Manchester and The Christie NHS Foundation Trust are one step closer to revolutionising how we diagnose cancer of unknown primary 👇
Often patients are diagnosed with secondary metastatic cancers, which means that the cancer cells have spread to other areas of the body. In rare cases, it can be difficult to find where the cancer started in the first place, called the primary tumour. In these cases, the person is diagnosed with cancer of unknown primary (CUP).
A CUP diagnosis makes it harder to know which treatment will be the most effective – the primary location is the key to this.
Dr Alicia-Marie Conway and her team have been working on a new test called CUPiD, which uses a marker called DNA methylation to reveal where the primary cancer started growing.
They hope to transform the treatment journey for patients with CUP by determining which treatments would work best for them earlier on in their cancer journey.
Read more: https://cruk.ink/3vZooL8
Researchers in Manchester are working to develop a blood test that could transform the diagnostic journey of someone with cancer of unknown primary